Markets:

Overview

News

Currencies

International

Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

281.05 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations

July 27, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

July 27, 2021

This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...

Via Benzinga

Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021

July 14, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products

June 30, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing

June 21, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

5 Value Stocks To Watch In The Healthcare Sector ↗

June 14, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

Bio-Rad to Participate at Jefferies Virtual Healthcare Conference

May 20, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

May 10, 2021

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...

Via Benzinga

Bio-Rad Laboratories Inc (BIO) Q1 2021 Earnings Call Transcript ↗

April 30, 2021

BIO earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Bio-Rad Reports First-Quarter 2021 Financial Results

April 29, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

A Preview Of Bio-Rad Laboratories's Earnings ↗

April 28, 2021

On Thursday, April 29, Bio-Rad Laboratories (NYSE:BIO) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

April 15, 2021

From Bio-Rad Laboratories, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today